Cordlife Group (SG:P8A) has released an update.
Cordlife Group Limited has received a seventh communication from SAC Capital on behalf of NJXJK, highlighting ongoing suspensions of their Singapore cord blood banking operations by MOH and the withdrawal of AABB accreditation. The future of the company’s operations remains uncertain as investigations continue and there is no clarity on when services may resume.
For further insights into SG:P8A stock, check out TipRanks’ Stock Analysis page.
